- Home
- COOP vs RNA Comparison
COOP vs RNA Comparison
Compare COOP & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COOP
- RNA
- Stock Information
- Founded
- COOP 2015
- RNA 2012
- Country
- COOP United States
- RNA United States
- Employees
- COOP N/A
- RNA N/A
- Industry
- COOP Finance: Consumer Services
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- COOP Finance
- RNA Health Care
- Exchange
- COOP Nasdaq
- RNA Nasdaq
- Market Cap
- COOP 5.3B
- RNA 5.5B
- IPO Year
- COOP N/A
- RNA 2020
- Fundamental
- Price
- COOP $96.18
- RNA $42.18
- Analyst Decision
- COOP Buy
- RNA Strong Buy
- Analyst Count
- COOP 9
- RNA 9
- Target Price
- COOP $95.67
- RNA $63.22
- AVG Volume (30 Days)
- COOP 628.3K
- RNA 1.1M
- Earning Date
- COOP 10-23-2024
- RNA 11-07-2024
- Dividend Yield
- COOP N/A
- RNA N/A
- EPS Growth
- COOP 18.37
- RNA N/A
- EPS
- COOP 7.72
- RNA N/A
- Revenue
- COOP $1,975,000,000.00
- RNA $10,117,000.00
- Revenue This Year
- COOP $23.52
- RNA $19.33
- Revenue Next Year
- COOP $26.26
- RNA $10.35
- P/E Ratio
- COOP $12.45
- RNA N/A
- Revenue Growth
- COOP 16.66
- RNA N/A
- 52 Week Low
- COOP $57.22
- RNA $5.68
- 52 Week High
- COOP $103.05
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- COOP 54.15
- RNA 42.17
- Support Level
- COOP $87.70
- RNA $45.65
- Resistance Level
- COOP $103.05
- RNA $56.00
- Average True Range (ATR)
- COOP 2.79
- RNA 3.33
- MACD
- COOP 0.45
- RNA 0.07
- Stochastic Oscillator
- COOP 55.24
- RNA 7.12
About COOP Mr. Cooper Group Inc.
Mr. Cooper Group Inc is a home loan servicer. The company focuses on delivering a variety of servicing and lending products. It has operating segments namely Servicing segment which performs operational activities on behalf of investors or owners of the underlying mortgages and mortgage servicing rights, including collecting and disbursing borrower payments, investor reporting, and customer service, The Originations segment originates residential mortgage loans through a direct-to-consumer channel, which provides refinance options for existing customers, and through a correspondent channel, which purchases or originates loans from mortgage bankers and brokers, and the Corporate segment. The Servicing segment of the company generates maximum revenue.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.